*From the Vitreous, Retina, Macula Consultants of New York, New York, NY †Department of Electrical Engineering & Computer Science and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA ‡Department of Ophthalmology, Tufts University School of Medicine, Boston MA Supported by the Macula Foundation, New York, NY, National Institutes of Health R01- EY011289-29, Air Force Office of Scientific Research FA9550-12-1-0449, and the Champalimaud Foundation. Richard F. Spaide receives royalty and consulting fees from Topcon Medical Systems and consultant fees from Genentech Inc. James G. Fujimoto has stock options in Optovue, Inc.; his employer receives royalty payments from Carl Zeiss Inc. and Optovue. Nadia K. Waheed has received consultant fees from Iconic Pharmaceuticals and Carl Zeiss Inc. and has received lecture fees from Thrombogenics Inc. None of the authors have any financial/conflicting interests to disclose.
No takes yet. Share an insight, caveat, or question.
Spaide et al. (2015) studied this question.